Josep Jové

ORCID: 0000-0003-0196-0372
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Brain Metastases and Treatment
  • Advanced Radiotherapy Techniques
  • Lung Cancer Treatments and Mutations
  • Cancer-related cognitive impairment studies
  • Advances in Oncology and Radiotherapy
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Bladder and Urothelial Cancer Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Esophageal Cancer Research and Treatment
  • Multiple and Secondary Primary Cancers
  • Advanced MRI Techniques and Applications
  • Lymphatic System and Diseases
  • Medical Imaging Techniques and Applications
  • Childhood Cancer Survivors' Quality of Life
  • Occupational and environmental lung diseases
  • Statistical Methods in Clinical Trials
  • Cardiac Imaging and Diagnostics
  • Patient Safety and Medication Errors
  • Global Cancer Incidence and Screening

Institut Català d'Oncologia
2011-2023

Hospital del Mar Research Institute
2021

Municipal Institute for Medical Research
2021

Hospital Del Mar
2021

Samsung Medical Center
2021

Georgetown University
2020

Georgetown University Medical Center
2020

Inserm
2020

Université de Bordeaux
2020

Hospital Universitari Germans Trias i Pujol
2009-2019

No study has examined structural brain changes specifically associated with chemotherapy in a lung cancer population. The aim of this cross-sectional was to assess differences structure between small-cell patients (C+) following chemotherapy, non-small-cell (C-) before and healthy controls (HC).Twenty-eight underwent neuropsychological assessment magnetic resonance imaging, including T1-weighted diffusion tensor imaging examine gray matter density white (WM) integrity, respectively, 1 month...

10.1097/jto.0000000000000345 article EN publisher-specific-oa Journal of Thoracic Oncology 2014-10-17

Abstract Background Prognostic indexes are useful to guide tailored treatment strategies for cancer patients with brain metastasis (BM). We evaluated the new Graded Assessment (GPA) scale in a prospective validation study compare it two published prognostic indexes. Methods A total of 285 newly diagnosed BM ( n = 85 synchronous BM) patients, accrued prospectively between 2000 and 2009, were included this analysis. Mean age was 62 ± 12.0 years. The median KPS number 70 (range, 20-100) 3...

10.1186/1748-717x-6-23 article EN cc-by Radiation Oncology 2011-03-02

The therapeutic approach to cancer is complex and multidisciplinary. Radiotherapy among the essential treatments, whether used alone or in conjunction with other therapies. This study reports a clinical audit of radiotherapy process assess care, evaluate adherence agreed protocols measure variability improve quality for rectal cancer.Multicentre retrospective cohort representative sample patients diagnosed Institut Català d'Oncologia, comprehensive centre three different settings. We...

10.1016/j.tranon.2018.03.015 article EN cc-by-nc-nd Translational Oncology 2018-04-25

Abstract Purpose To assess the validity, reliability, and responsiveness of Spanish version Expanded Prostate cancer Index Composite (EPIC) with 26 items. Methods Multicentric longitudinal study patients diagnosed localized or locally advanced prostate (any T, any N, M0) treated active surveillance, surgery, external radiotherapy, brachytherapy. The EPIC-50 was administered initially to cohort ( n = 324 patients), until it replaced in November 2019 by EPIC-26 543), both groups before...

10.1007/s00345-023-04691-7 article EN cc-by World Journal of Urology 2023-11-10

Conclusion:There is evidence to suggest a dose volume effect between the PB and EP.Discriminatory dosevolume constraints were found predict G2 EP.Further analysis in progress include patient reported outcomes related EP.

10.1016/s0167-8140(16)31591-2 article EN cc-by-nc-nd Radiotherapy and Oncology 2016-04-01

e22139 Background: During the last years, new predictive and less frequent biomarkers have emerged in NSCLC, such as ROS1 translocation (ROS1t), HER2 mutations (HER2m) BRAF (BRAFm). We analyze retrospectively frequency, clinical tumor characteristics of NSCLC p TN( EGFR, KRAS ALK wild-type). Methods: The study included data from all consecutive non-squamous non-smokers squamous TN advanced diagnosed at our hospital December 2008 to July 2014. Results: 101 were included. table below...

10.1200/jco.2015.33.15_suppl.e22139 article EN Journal of Clinical Oncology 2015-05-20

To assess adherence to standard clinical practice for the diagnosis and treatment of patients undergoing prostate cancer (PCa) radiotherapy in four European countries using audits as part international IROCA project. Multi-institutional, retrospective cohort study 240 randomly-selected treated PCa (n = 40/centre) year 2015 at six hospitals. Clinical indicators applicable general PCa-specific processes were evaluated. All data obtained directly from medical records. The performed 2017....

10.1038/s41598-021-91723-0 article EN cc-by Scientific Reports 2021-06-10

PURPOSE: The long-term toxic effects of prophylactic cranial irradiation (PCI) on cognition in small cell lung cancer (SCLC) patients have not yet been well-established. aim our study was to examine the changes neuropsychological variables and brain structure a group SCLC survivors treated with PCI. PATIENTS AND METHODS: Eleven patients, who underwent PCI at least two years before were compared an age education matched healthy control group. Both groups evaluated using battery multimodal...

10.1093/neuonc/nou174.18 article EN Neuro-Oncology 2014-09-01
Coming Soon ...